| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |